Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
5
Teradata Corp
TDC
US OptionsDetailed Quotes
ACIU250516P2500
- 0.60
- 0.000.00%
15min DelayClose Apr 24 13:11 ET
0.00High0.00Low
0.60Open0.60Pre Close0 Volume171 Open Interest2.50Strike Price0.00Turnover0.00%IV-14.46%PremiumMay 16, 2025Expiry Date0.84Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.77Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AC Immune Newsroom
AC Immune SA: Promising Phase 2 Results and Positive Outlook Drive Buy Rating
H.C. Wainwright Maintains AC Immune(ACIU.US) With Buy Rating, Maintains Target Price $16
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and AC Immune SA (ACIU)
AC Immune's Strategic Advances and Financial Highlights
AC Immune Announces Additional Data From Phase 2 Study of VacSYn Clinical Trial
Express News | AC Immune Reports Further Positive Interim Results From Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Express News | AC Immune SA - ACI-7104.056 Is Well Tolerated With No Safety Issues Reported to Date
AC Immune Reports Further Positive Interim Results From Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease
Investors Don't See Light At End Of AC Immune SA's (NASDAQ:ACIU) Tunnel And Push Stock Down 25%
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD 2025
ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?
Promising Developments in AC Immune SA's ACI-7104 Program Drive Buy Rating
AC Immune (NASDAQ:ACIU) Investors Are Sitting on a Loss of 52% If They Invested Five Years Ago
Express News | HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target
AC Immune Analyst Ratings
AC IMMUNE SA Earnings Results: $ACIU Reports Quarterly Earnings
AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)
AC Immune | 20-F: FY2024 Annual Report
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call